Cerebral palsy is a dubious disease in the field of genetic metabolism, clinical manifestations are complex and often involve multi-systematic stress. Early identification and normalisation of the disease are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological tests.
The platform can help to align national and international authorities with teams to provide accurate diagnosis and treatment. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic diseases have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment to changes in the course of the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of coronary artery disease. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.